Adherence to disease-modifying therapies for multiple sclerosis and subsequent hospitalizations-Reference-Cited by-同舟云学术

Adherence to disease-modifying therapies for multiple sclerosis and subsequent hospitalizations

Published:2017-04-03 Issue:6 Volume:26 Page:702-711
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Evans Charity¹^ORCID,Marrie Ruth Ann²,Zhu Feng³,Leung Stella⁴,Lu Xinya⁵,Kingwell Elaine³,Zhao Yinshan³,Tremlett Helen³

Affiliation:

1. College of Pharmacy & Nutrition; University of Saskatchewan; Saskatoon SK Canada

2. Departments of Internal Medicine and Community Health Sciences; University of Manitoba; Winnipeg MB Canada

3. Department of Medicine (Neurology); University of British Columbia; Vancouver BC Canada

4. Department of Community Health Sciences; University of Manitoba; Winnipeg MB Canada

5. Saskatchewan Health Quality Council; Saskatoon SK Canada

Funder

National Multiple Sclerosis Society

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference57 articles.

1. Canadian Institute for Health Information National health expenditure trends, 1975 to 2015 2015 https://www.cihi.ca/sites/default/files/document/nhex_trends_narrative_report_2015_en.pdf

2. Weiss A Elixhauser A Overview of hospital stays in the United States, 2012 2014 http://www.hcup-us.ahrq.gov/reports/statbriefs/sb180-Hospitalizations-United-States-2012.pdf

3. Health spending, access, and outcomes: trends in industralized countries;Anderson;Health Aff,1999

4. The use of hospital admission data as a measure of outcome in clinical studies of heart failure;Metcalfe;Eur Heart J,2003

5. Association between beta-interferon exposure and hospital events in multiple sclerosis;Evans;Pharmacoepidemiol Drug Saf,2014

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Narrative Review on the Use of Cladribine Tablets as Exit Therapy for Stable Elderly Patients with Multiple Sclerosis;Neurology and Therapy;2024-04-08

2. ESCLEROSE MÚLTIPLA - ABORDAGENS DIAGNÓSTICAS E TERAPÊUTICAS: UMA REVISÃO BIBLIOGRÁFICA;RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218;2024-02-29

3. Polypharmacy in patients with multiple sclerosis and the impact on levels of care and therapy units;Frontiers in Neurology;2023-12-21

4. Impact of adherence to disease-modifying drugs in multiple sclerosis: A study on Italian real-world data;Multiple Sclerosis and Related Disorders;2023-12

5. Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation;Expert Review of Clinical Immunology;2023-09-11